Skip to main content
OpenTrials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

367 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

NSCLC trial results

Active, not recruiting

Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients

NCT04223596

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Complejo Hospitalario de A Coruña A Coruña, Spain
  • Hospital General de Alicante Alicante, Spain
  • Hospital Regional Universitario de Málaga Málaga, Andalusia, Spain
  • Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain
View all 15 locations
View Trial Details
Active, not recruiting

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

NCT04367311

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +6 more
Locations
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Summit Health Berkeley Heights, New Jersey, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Active, not recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details
Active, not recruiting

A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

NCT05117476

Conditions
Advanced Solid Tumor, NSCLC
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • City of Hope Irvine, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 24 locations
View Trial Details
Active, not recruiting

A Phase 1/2 Study of BA3071 in Patients With Solid Tumors

NCT05180799

Conditions
Melanoma, NSCLC, Neoplasm Metastasis, +14 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Piedmont West Atlanta, Georgia, United States
  • Northwest Cancer Centers Dyer, Indiana, United States
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression

NCT05736731

Conditions
Bronchial Neoplasms, CRC, Cancer, +38 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions